Abbott Stays Ahead Of Edwards In Transcatheter Mitral Valve Race With Tendyne CE Mark

 
• By Reed Miller

Tendyne is indicated for the treatment of significant mitral regurgitation in patients who are not candidates for surgery. It complements Abbott’s MitraClip mitral valve repair device and is an important part of the company’s strategy to be the leading structural heart device company.

Tendyne
Abbott's Tendyne transcatheter mitral valve system • Source: Abbott Laboratories

More from Approvals

More from Policy & Regulation